You are here

  • Home
  • Archive
  • Volume 2, Issue 1
  • Radioimmunotargeting in ovarian carcinoma patients with indium-111 labeled monoclonal antibody OV-TL 3 F(ab′)2: pharmacokinetics, tissue distribution, and tumor imaging

Article info

Article menu
Download PDFPDF
Original Articles
Radioimmunotargeting in ovarian carcinoma patients with indium-111 labeled monoclonal antibody OV-TL 3 F(ab′)2: pharmacokinetics, tissue distribution, and tumor imaging

Authors

  1. Address for correspondence: Professor Dr P. Kenemans, Department of Obstetrics and Gynecology, Free University Hospital, PO box 7057, 1007 MB Amsterdam, The Netherlands.

Citation

BUIST MR, KENEMANS P, VERMORKEN JB, et al
Radioimmunotargeting in ovarian carcinoma patients with indium-111 labeled monoclonal antibody OV-TL 3 F(ab′)2: pharmacokinetics, tissue distribution, and tumor imaging
International Journal of Gynecologic Cancer 1992;2:23-34.

Publication history

  • First published January 1, 1992.
Online issue publication 
February 26, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

International Gynecologic Cancer Society